SuperCrowd
New offering · Form C
A company's offering statement — it's kicking off a Regulation Crowdfunding raise.
Bioclonetics Immunotherapeutics, Inc.
bioclonetics.com · TX · Filed Apr 11, 2017
Bioclonetics Immunotherapeutics, Inc. filed a Form C — new offering — with the SEC on Apr 11, 2017. The Regulation Crowdfunding offering seeks $200,000, up to a maximum of $1,000,000 on Wefunder. Investors receive: Other at $1.00. The offering closes Aug 10, 2017.
| Target raise | $200,000 |
|---|---|
| Maximum raise | $1,000,000 |
| Security | Other @ $1.00 |
| Closes | Aug 10, 2017 |
| Portal | Wefunder |
| SEC file number | 020-23301 · every filing in this offering |
Filing documents
Document 1
Document 2
Document 3
Document 4
Document 5
Document 6
Document 7
Document 8
Document 9
Document 10
Document 11
Document 12
The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.